Login to Your Account

Active Biotech Shares Climb on Ipsen Milestone

By Cormac Sheridan
Staff Writer

Tuesday, May 22, 2012
Shares in Active Biotech AB climbed more than 12 percent Monday on news that the company earned a €10 million milestone payment from its partner, Ipsen SA, after reaching the halfway point in recruitment onto a 1,200-patient, Phase III registration trial of tasquinimod in metastatic castrate-resistant prostate cancer.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription